Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination
Trial details
- Registry ID
- NCT00053495
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox VaccinationNCT00053495 | Emergent BioSolutions | Phase 2 | Completed | 2003-06Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |